A Letter to our Community: Women’s Health in Today’s America

Amboy Street Ventures is excited to announce its latest investment in Gesynta Pharma - developing a novel non-hormonal drug candidate for the treatment of endometriosis.

This blog highlights one of the largest growth capital investments made in Femtech this year. Led by General Atlantic, the deal highlights a growing interest in the women’s health sector from prominent generalist firms.

This week we highlight a second acquisition by the active women’s health acquirer, Hologic, in a large market segment of women’s health: breast cancer.

This week we explore one of a growing number of consolidation plays in the IVF space, IVI RMA’s acquisition of Boston IVF and TRIO. This trend suggests there is value in 4-wall IVF clinics, reflecting an interesting area of investment.

This blog assesses a recent women’s health deal that expands treatment options for uterine fibroids and abnormal uterine bleeding. These indications are infrequently discussed and therefore unfamiliar to many, yet impact a significant number of women, especially those in perimenopause.

This week we delve into a major acquisition touching multiple areas of women’s health. A deal like this demonstrates a strong appetite for women’s health innovation, across indications, as acquirers recognize the financial viability in meeting these needs.

Amboy Street Ventures is excited to announce its latest investment in Alloy Women’s Health, a digital health company committed to providing women the care they need through menopause and beyond.

In this blog, we unpack prenatal genetic screening company, BillionToOne's $130 million Series D raise to showcase the increasing number of women’s health companies reaching unicorn status. We are seeing women’s health companies close considerable growth rounds while early-stage funding remains robust.

This week we explore a major acquisition in a segment of women’s health that is often stigmatized yet universally experienced by women at some point in their lifetime: urinary incontinence.